Status:
UNKNOWN
Internet-based Cognitive Behavioral Therapy for Chronic Tic Disorder and Tourette's Disorder: a Feasibility Trial
Lead Sponsor:
Karolinska Institutet
Collaborating Sponsors:
Region Stockholm
Conditions:
Chronic Tic Disorder
Tourette Syndrome
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Tic disorders, including Tourette's Disorder (TD) and Chronic Motor or Vocal Tic Disorder (CTD), are neurodevelopmental motor disorders characterised by motor and/or vocal tics. TD/CTD are impairing c...
Detailed Description
Background TS (Tourette Syndrome) is characterized by multiple motor tics and one or more vocal tics that have persisted for at least one year since initial onset, whereas in Chronic Motor or Vocal T...
Eligibility Criteria
Inclusion
- The participant should
- be 18 years of age or older,
- fulfill diagnostic criteria for Tourette's Disorder (from now on referred to as Tourette Syndrome; TS) or Persistent (Chronic) Motor or Vocal Tic Disorder (CTD) according to the DSM-5 diagnostic criteria,
- have Total Tic Severity Score \[TTSS\] of \>15, or \>10 for individuals with motor or vocal tics only, in the past week as measured by the Yale Global Tic Severity Scale (YGTSS) (31) ,
- be able to read and communicate in Swedish and
- have regular access to a computer connected to the internet, sufficient technical skills to use the treatment platform, as well as a mobile phone to receive SMS.
Exclusion
- organic brain disorders, intellectual disability, psychosis, bipolar disorder, autism spectrum disorder, anorexia nervosa, or substance use disorders,
- acute psychiatric problems such as severe depression or suicidal risk needing immediate psychiatric care,
- severe tics causing immediate risk to the patients or others and requiring urgent medical attention,
- previous CBT for tics of a minimum of 8 sessions with a qualified therapist within 12 months prior to assessment,
- simultaneous psychological treatment for TS or CTD
- initiation or adjustment of medication for tics within the last two months prior to assessment.
Key Trial Info
Start Date :
April 15 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 23 2023
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT04908969
Start Date
April 15 2021
End Date
August 23 2023
Last Update
October 28 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
OCD-clinic, Psykiatri Sydväst, Huddinge hospital
Huddinge, Sweden, 14157